Stay updated with breaking news from Hcell Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DelveInsight's Medullary Thyroid Cancer Pipeline Insight 2023 report provides comprehensive global Medullary Thyroid Cancer coverage of available, marketed, and Medullary Thyroid Cancer Pipeline...
CityWatch is published 24/7 with special e-news blasts on Monday and Thursday evening, with Extras as appropriate around special events such as elections or imp
/PRNewswire/ -- The "Global Alopecia Treatment Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. The global...
/PRNewswire/ -- The "Global Alopecia Treatment Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. The global...
SEONGNAM, South Korea--(BUSINESS WIRE)--#CAR_NK--GI CELL, Inc. announced today that it has entered into a research license and option agreement with Optieum Biotechnologies, Inc. (Japan). Under the agreement, Optieum Biotechnologies will provide GI CELL with scFv antibodies directed against hematological tumor targe...